Navigation Links
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
Date:9/19/2007

ROCKVILLE, Md., Sept. 19 /PRNewswire-FirstCall/ -- Stem cell company, Neuralstem, Inc. (AMEX: CUR), announced today that it has received notice that the United States Patent and Trademark Office (USPTO) has issued its first ruling in the reexamination of the four StemCells, Inc. (Nasdaq: STEM) patents requested by Neuralstem.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

"The Patent Office has rejected on multiple grounds all of the claims in all four of StemCells' patents that it examined," said Neuralstem President & CEO, Richard Garr. "In accepting the reexamination months ago," Garr explained, "the Patent Office was only ruling that, on its face, there was enough evidence to disallow the claims. Now after careful examination, the Patent Office has issued an official rejection of each of the claims in all four of the patents that StemCells attempted to assert against Neuralstem in its law suit. Importantly the Patent Office is rejecting the StemCells patents based on additional prior art references that were not even the focus of our reexamination request. We are pleased but certainly not surprised by the Patent Office's rejection of all the claims in all the relevant StemCells patents," Garr went on to say. "We believe that the Patent Office has now correctly found that these claims should never have been issued in the first place."

About Neuralstem

Neuralstem's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into matu
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Changes to U.S. patent law must nurture our culture of innovation
2. WARF questions relevancy of documents used to uphold patent challenge
3. Supreme Court limits foreign reach of U.S. patents
4. High court sends message on patent obviousness
5. Supreme Court ruling seen as blow to WARF stem cell patents
6. Patent licensing: For enforcing companies, the rules have changed
7. Patent ruling doesnt tarnish Wisconsins stem cell leadership
8. Heres why Wisconsins stem cell patents are being challenged
9. WARF is likely to hold on to stem cell patent rights
10. Patent office upholds challenge to WARF stem cell patents
11. Rocket docket speeds patent infringement suits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
(Date:12/24/2014)... 23, 2014 GMO corn cases filed across ... in the process of being consolidated in a Kansas federal ... Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in ... Management of the Syngenta GMO corn multidistrict litigation (MDL) has ...
(Date:12/24/2014)... 2014 The report provides basic ... classification, application and industry overview. This report also ... structure. Production is separated by regions, technology and ... equipment, downstream client survey, marketing channels, industry development ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... 28 f-star, an antibody,engineering company developing novel antibodies ... today announced that it,has raised EUR 3.0 million from ... financing round, originally co-led by Aescap Venture and Atlas ... Series A round,increases to EUR 9.0 million. In total, ...
... Va., Nov. 28 LifeNet Health,a leading ... with IMS (Integrated Medical Systems International, Inc.), ... for LifeNet,Health customers, improving the tracking of ... the development, marketing, distribution, and,support of a ...
... Fla., Nov. 28 News briefs concerning the,economic and ... Tampa Bay,Partnership:, SRI Launches First Major Project to ... a five-year, $36.5 million contract,to develop a Maritime Domain ... technologies for improving port security in,the United States. The ...
Cached Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3LifeNet Health and IMS Announce Partnership 2Highlights of Economic and Business Growth in the Tampa Bay Region 2Highlights of Economic and Business Growth in the Tampa Bay Region 3Highlights of Economic and Business Growth in the Tampa Bay Region 4
(Date:12/22/2014)... (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the ... commerce market, announces it has retained famous pickpocket, entertainer and ... CES debut of the Wocket™ biometric smart wallet.  ... booth January 6th and 7 th , 2015, demonstrating some ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... 2012 BONESUPPORT, ein aufstrebendes Unternehmen im ... und Instrumentenzusätze für orthopädische Chirurgie, gab heute ... Marktführerschaft im Bereich Innovation und Technologie unter ... als einer der Top 100-Gewinner für den ...
... School of Dentistry have made an important connection ... high blood pressure. Production of the molecule Brain-Derived ... blood pressure-sensing nerve cells during hypertension. The study, ... Research , may someday have implications for the ...
... Press coverage of synthetic biology in the United States and ... report released today by the Synthetic Biology Project at the ... Trends in American and European Press Coverage of Synthetic Biology: ... US-EU press coverage between 2003 and 2008. Synthetic biology, an ...
Cached Biology News:BONESUPPORT für 2012 Top 100 Global Award von Red Herring ausgewählt 2BONESUPPORT für 2012 Top 100 Global Award von Red Herring ausgewählt 3New report finds increase in media coverage of synthetic biology 2
Request Info...
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
in vitro Translation, Accessory Products...
... K-12 derivatives that have mutations in both ... (gor) genes, which greatly enhances disulfide bond ... that expression in Origami(DE3) yielded 10-fold more ... though overall expression levels were similar (1). ...
Biology Products: